Literature DB >> 28625576

Mexiletine co-injected with clonidine increases the quality and duration of cutaneous analgesia in response to skin pinpricks in the rat.

Ming-Ming Han1, Chong-Chi Chiu2, Jhi-Joung Wang3, Yu-Wen Chen4, Ching-Hsia Hung5.   

Abstract

The goal of the experimental design was to assess the cutaneous analgesic effect of mexiletine by co-injection with clonidine. The effect of nociceptive block was evaluated according to the inhibition of the cutaneous trunci muscle reflex (CTMR) in response to skin pinpricks in rats. The dose-related analgesic effect of mexiletine alone or mexiletine co-administrated with clonidine was constructed after subcutaneous injection. Subcutaneous injections of mexiletine elicited dose-related cutaneous analgesia. Compared with mexiletine (1.8μmol), adding clonidine to mexiletine (1.8μmol) solutions for skin nociceptive block potentiated and prolonged the action (p<0.01). Mexiletine (6μmol) combined with clonidine extended the duration of cutaneous analgesia when compared with mexiletine (6μmol) alone (p<0.01). Co-administration of clonidine increases the potency and extends the duration of cutaneous analgesia by mexiletine, and the minimal dose of clonidine to intensify the analgesic effect is 0.06μmol.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clonidine; Co-administration; Infiltrative cutaneous analgesia; Mexiletine; Pinpricks

Mesh:

Substances:

Year:  2017        PMID: 28625576     DOI: 10.1016/j.neulet.2017.06.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  A comparative study of serotonin and norepinephrine as adjuncts to improve cutaneous antinociception of mexiletine in response to skin pinpricks in rats.

Authors:  Mingming Han; Fang Kang; Chengwei Yang; Mingyu Zhai; Kesong Zheng; Ting Wang; Ziyou Liu; Juan Li
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.